Disc Medicine (NASDAQ:IRON) Earns “Outperform” Rating from Wedbush
Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a report released on Monday,RTT News reports. They currently have a $90.00 target price on the stock. Wedbush’s target price suggests a potential upside of 79.82% from the stock’s previous close. Several other equities analysts have […]
Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a report released on Monday,RTT News reports. They currently have a $90.00 target price on the stock. Wedbush’s target price suggests a potential upside of 79.82% from the stock’s previous close. Several other equities analysts have […]
